The Changing Face of Beauty, a global study conducted by Allergan, reflects a shift in consumer expectations; women today opt for products and procedures to improve how they feel, rather than simply how they look.
The FDA has agreed to evaluate an anti-wrinkle injection treatment
from France-based pharmaceutical company Ipsen which if approved
would provide a rival for Allergan's Botox.